Human gene
COL5A2 collagen type V alpha 2
1 disease group in OMIA reaches this gene, through the animal gene that Ensembl gives as its ortholog. The page shows the chain. It does not say whether an animal is a model of a human disease.
Animal diseases
By each group's best natural-model score, highest first. How the score works.
| OMIA group | Name | Species | Animal gene | Ortholog | The chain reached | Best score |
|---|---|---|---|---|---|---|
| 2295 | classical Ehlers-Danlos syndrome (cEDS), COL5A2-related | dog | COL5A2 | one to one | Drug |
65.4
|
| 2295 | classical Ehlers-Danlos syndrome (cEDS), COL5A2-related | domestic cattle | COL5A2 | one to one | Drug |
65.4
|
Target evidence
Each Open Targets association between this gene and a human disease that a disease group reached.
| Human disease | Mondo | Score | Evidence |
|---|---|---|---|
| Ehlers-Danlos syndrome, classic type, 2 | MONDO:0019568 | 0.74 | 241 |
Drugs
Each ChEMBL drug that acts on this gene.
| Drug | How | Latest stage |
|---|---|---|
| Collagenase Clostridium Histolyticum | hydrolytic enzyme | Approved |
| Ocriplasmin | hydrolytic enzyme | Approved |
The drug data is ChEMBL's, under CC BY-SA 3.0, and came through Open Targets release 26.09.